Selected research
Industry Research
Neurotrophins Industry Research Report 2026
Market perspective
The global Neurotrophins market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Neurotrophins is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Neurotrophins is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Neurotrophins is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Neurotrophins include FibroGen, GE Healthcare, Merck Serono, PeproTech, Scil Proteins GmbH, Scil Proteins GmbH, Lonza Groups and Johnson＆Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Neurotrophins market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neurotrophins Market by Company
FibroGen
GE Healthcare
Merck Serono
PeproTech
Scil Proteins GmbH
Scil Proteins GmbH
Lonza Groups
Johnson＆Johnson
Neurotrophins Segment by Type
Dehydroepiandrosterone Sulfate
Brain-Derived Neurotrophic Factor
Nerve Growth Factor
Other
Neurotrophins Segment by Application
Alzheimer'S Disease
Amyotrophic Lateral Sclerosis
Parkinson'S Disease
Other
Neurotrophins Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurotrophins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurotrophins and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurotrophins.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Neurotrophins manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Neurotrophins by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Neurotrophins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dehydroepiandrosterone Sulfate
- Brain-Derived Neurotrophic Factor
- Nerve Growth Factor
- Other
Applications
- Alzheimer'S Disease
- Amyotrophic Lateral Sclerosis
- Parkinson'S Disease
- Other
Companies covered
- FibroGen
- GE Healthcare
- Merck Serono
- PeproTech
- Scil Proteins GmbH
- Scil Proteins GmbH
- Lonza Groups
- Johnson＆Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Neurotrophins Market Size (2021-2032)
- 2.2.2 Global Neurotrophins Sales (2021-2032)
- 2.2.3 Global Neurotrophins Market Average Price (2021-2032)
- 2.3 Neurotrophins by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Dehydroepiandrosterone Sulfate
- 2.3.3 Brain-Derived Neurotrophic Factor
- 2.3.4 Nerve Growth Factor
- 2.3.5 Other
- 2.4 Neurotrophins by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Alzheimer'S Disease
- 2.4.3 Amyotrophic Lateral Sclerosis
- 2.4.4 Parkinson'S Disease
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Neurotrophins Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Neurotrophins Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Neurotrophins Revenue of Manufacturers (2021-2026)
- 3.4 Global Neurotrophins Average Price by Manufacturers (2021-2026)
- 3.5 Global Neurotrophins Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Neurotrophins, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Neurotrophins, Product Type & Application
- 3.8 Global Manufacturers of Neurotrophins, Established Date
- 3.9 Global Neurotrophins Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 FibroGen
- 4.1.1 FibroGen Company Information
- 4.1.2 FibroGen Business Overview
- 4.1.3 FibroGen Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 FibroGen Neurotrophins Product Portfolio
- 4.1.5 FibroGen Recent Developments
- 4.2 GE Healthcare
- 4.2.1 GE Healthcare Company Information
- 4.2.2 GE Healthcare Business Overview
- 4.2.3 GE Healthcare Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GE Healthcare Neurotrophins Product Portfolio
- 4.2.5 GE Healthcare Recent Developments
- 4.3 Merck Serono
- 4.3.1 Merck Serono Company Information
- 4.3.2 Merck Serono Business Overview
- 4.3.3 Merck Serono Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Serono Neurotrophins Product Portfolio
- 4.3.5 Merck Serono Recent Developments
- 4.4 PeproTech
- 4.4.1 PeproTech Company Information
- 4.4.2 PeproTech Business Overview
- 4.4.3 PeproTech Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 PeproTech Neurotrophins Product Portfolio
- 4.4.5 PeproTech Recent Developments
- 4.5 Scil Proteins GmbH
- 4.5.1 Scil Proteins GmbH Company Information
- 4.5.2 Scil Proteins GmbH Business Overview
- 4.5.3 Scil Proteins GmbH Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Scil Proteins GmbH Neurotrophins Product Portfolio
- 4.5.5 Scil Proteins GmbH Recent Developments
- 4.6 Scil Proteins GmbH
- 4.6.1 Scil Proteins GmbH Company Information
- 4.6.2 Scil Proteins GmbH Business Overview
- 4.6.3 Scil Proteins GmbH Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Scil Proteins GmbH Neurotrophins Product Portfolio
- 4.6.5 Scil Proteins GmbH Recent Developments
- 4.7 Lonza Groups
- 4.7.1 Lonza Groups Company Information
- 4.7.2 Lonza Groups Business Overview
- 4.7.3 Lonza Groups Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lonza Groups Neurotrophins Product Portfolio
- 4.7.5 Lonza Groups Recent Developments
- 4.8 Johnson＆Johnson
- 4.8.1 Johnson＆Johnson Company Information
- 4.8.2 Johnson＆Johnson Business Overview
- 4.8.3 Johnson＆Johnson Neurotrophins Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Johnson＆Johnson Neurotrophins Product Portfolio
- 4.8.5 Johnson＆Johnson Recent Developments
5 Global Neurotrophins Market Scenario by Region
- 5.1 Global Neurotrophins Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Neurotrophins Sales by Region: 2021-2032
- 5.2.1 Global Neurotrophins Sales by Region: 2021-2026
- 5.2.2 Global Neurotrophins Sales by Region: 2027-2032
- 5.3 Global Neurotrophins Revenue by Region: 2021-2032
- 5.3.1 Global Neurotrophins Revenue by Region: 2021-2026
- 5.3.2 Global Neurotrophins Revenue by Region: 2027-2032
- 5.4 North America Neurotrophins Market Facts & Figures by Country
- 5.4.1 North America Neurotrophins Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Neurotrophins Sales by Country (2021-2032)
- 5.4.3 North America Neurotrophins Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Neurotrophins Market Facts & Figures by Country
- 5.5.1 Europe Neurotrophins Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Neurotrophins Sales by Country (2021-2032)
- 5.5.3 Europe Neurotrophins Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Neurotrophins Market Facts & Figures by Country
- 5.6.1 Asia Pacific Neurotrophins Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Neurotrophins Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Neurotrophins Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Neurotrophins Market Facts & Figures by Country
- 5.7.1 South America Neurotrophins Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Neurotrophins Sales by Country (2021-2032)
- 5.7.3 South America Neurotrophins Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Neurotrophins Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Neurotrophins Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Neurotrophins Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Neurotrophins Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Neurotrophins Sales by Type (2021-2032)
- 6.1.1 Global Neurotrophins Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Neurotrophins Sales Market Share by Type (2021-2032)
- 6.2 Global Neurotrophins Revenue by Type (2021-2032)
- 6.2.1 Global Neurotrophins Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Neurotrophins Revenue Market Share by Type (2021-2032)
- 6.3 Global Neurotrophins Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Neurotrophins Sales by Application (2021-2032)
- 7.1.1 Global Neurotrophins Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Neurotrophins Sales Market Share by Application (2021-2032)
- 7.2 Global Neurotrophins Revenue by Application (2021-2032)
- 7.2.1 Global Neurotrophins Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Neurotrophins Revenue Market Share by Application (2021-2032)
- 7.3 Global Neurotrophins Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Neurotrophins Value Chain Analysis
- 8.1.1 Neurotrophins Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Neurotrophins Production Mode & Process
- 8.2 Neurotrophins Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Neurotrophins Distributors
- 8.2.3 Neurotrophins Customers
9 Global Neurotrophins Analyzing Market Dynamics
- 9.1 Neurotrophins Industry Trends
- 9.2 Neurotrophins Industry Drivers
- 9.3 Neurotrophins Industry Opportunities and Challenges
- 9.4 Neurotrophins Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst